13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001442756
申报总市值
US$11.7亿
US$11.7亿
56 檔
38.5%
截至 Q2 2025 季度末，PFM Health Sciences, LP 的美股持仓估值约为 US$11.7亿，全数申报仓位共有 56 档。
在 Q2 2025，PFM Health Sciences, LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 23 个仓位并完全清仓 26 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，PFM Health Sciences, LP 的前 5 大核心持股（包含 LLY, THC, MCK 等）合计占整体申报市值的 38.5%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 股票-医疗保健 | 17.79% | -1.48% | -2.10% | |
| 2 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 7.48% | -4.83% | +1.61% | |
| 3 | MCK | Mckesson CORP | 股票-医疗保健 | 4.51% | — | -25.83% | |
| 4 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 4.29% | +0.54% | -13.20% | |
| 5 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 4.12% | — | -4.41% | |
| 6 | PEN | Penumbra Inc | 股票-医疗保健 | 3.63% | -2.56% | — | |
| 7 | ASND | Ascendis Pharma A/S | 股票-其他 | 3.26% | -3.64% | EXIT | |
| 8 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 2.90% | -0.76% | EXIT | |
| 9 | CVS | Cvs Health CORP | 股票-医疗保健 | 2.81% | +1.22% | NEW | |
| 10 | OM | Outset Medical Inc | 股票-其他 | 2.72% | +0.01% | -1.25% | |
| 11 | DHR | Danaher CORP | 股票-医疗保健 | 2.71% | — | +43.51% | |
| 12 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 2.65% | +1.72% | +177.47% | |
| 13 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 2.61% | +0.08% | +3.30% | |
| 14 | ASND 2.25 04-01-28债券 | Ascendis Pharma A/s | 债券 | 2.46% | -1.54% | EXIT | |
| 15 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 2.36% | -0.49% | -6.68% | |
| 16 | HUM | Humana Inc | 股票-医疗保健 | 2.28% | +3.22% | NEW | |
| 17 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 2.17% | — | +22.33% | |
| 18 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 2.00% | — | -17.13% | |
| 19 | BBIO | Bridgebio Pharma Inc | 股票-医疗保健 | 1.92% | -0.13% | -42.54% | |
| 20 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 1.77% | — | — | |
| 21 | INDV | Indivior Pharmaceuticals, Inc. | 股票-其他 | 1.70% | — | +16.91% | |
| 22 | NTRA | Natera Inc | 股票-医疗保健 | 1.46% | -0.58% | — | |
| 23 | COR | Cencora Inc | 股票-医疗保健 | 1.36% | +0.86% | NEW | |
| 24 | MASI* | Masimo CORP | 股票-其他 | 1.35% | — | — | |
| 25 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 1.34% | +0.75% | -14.61% | |
| 26 | WAT | Waters CORP | 股票-医疗保健 | 1.28% | +0.85% | -16.91% | |
| 27 | AKRO | Akero Therapeutics Inc | 股票-其他 | 1.21% | — | — | |
| 28 | HO1 | Hologic Inc | 股票-其他 | 1.18% | — | — | |
| 29 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 1.16% | +0.67% | NEW | |
| 30 | ARQT | Arcutis Biotherapeutics Inc | 股票-其他 | 1.10% | +0.54% | NEW | |
| 31 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 1.09% | +1.45% | +114.88% | |
| 32 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 0.90% | — | — | |
| 33 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 0.89% | -4.03% | — | |
| 34 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 0.83% | — | — | |
| 35 | ✓ | Merus N V | 股票-其他 | 0.82% | — | — | |
| 36 | VRNA | Verona Pharma PLC - Adr | 股票-其他 | 0.65% | — | — | |
| 37 | ABBV | Abbvie Inc | 股票-医疗保健 | 0.64% | — | -87.71% | |
| 38 | 2655787D | Blueprint Medicines CORP | 股票-其他 | 0.53% | — | +4.29% | |
| 39 | NEO | Neogenomics Inc | 股票-医疗保健 | 0.48% | -1.21% | EXIT | |
| 40 | CMPS | Compass Pathways PLC | 股票-其他 | 0.42% | -0.39% | +294.28% | |
| 41 | AMLX | Amylyx Pharmaceuticals Inc | 股票-其他 | 0.40% | +0.04% | -12.21% | |
| 42 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 0.39% | -1.91% | EXIT | |
| 43 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 0.34% | +0.06% | -89.51% | |
| 44 | PRAX | Praxis Precision Medicines I | 股票-其他 | 0.30% | +0.07% | -47.34% | |
| 45 | INBX | Inhibrx Biosciences Inc | 股票-其他 | 0.30% | +0.64% | -44.40% | |
| 46 | IOBTQ | Io Biotech Inc | 股票-其他 | 0.23% | — | -15.76% | |
| 47 | QURE | uniQure N.V. | 股票-其他 | 0.21% | +0.04% | -70.94% | |
| 48 | RZLT | Rezolute Inc | 股票-其他 | 0.16% | +0.02% | — | |
| 49 | CRBU | Caribou Biosciences Inc | 股票-其他 | 0.15% | -0.12% | -45.79% | |
| 50 | IRON | Disc Medicine Inc | 股票-其他 | 0.14% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | THC | Tenet Healthcare CORP | +2.7% | +1.61% | 加仓 |
| 2 | TEVA | Teva Pharmaceutical-sp Adr | +1.8% | NEW | 新建仓 |
| 3 | NTRA | Natera Inc | +1.5% | NEW | 新建仓 |
| 4 | LLY | Eli Lilly & Co | +1.4% | -2.10% | 减仓 |
| 5 | OM | Outset Medical Inc | +1.4% | -1.25% | 减仓 |
| 6 | COR | Cencora Inc | +1.4% | NEW | 新建仓 |
| 7 | MASI* | Masimo CORP | +1.4% | NEW | 新建仓 |
| 8 | UNH | Unitedhealth Group Inc | +1.3% | +177.47% | 加仓 |
| 9 | CVS | Cvs Health CORP | +1.3% | +53.38% | 加仓 |
| 10 | AKRO | Akero Therapeutics Inc | +1.2% | NEW | 新建仓 |
| 11 | HO1 | Hologic Inc | +1.2% | NEW | 新建仓 |
| 12 | IRTC | Irhythm Holdings Inc | +1.2% | NEW | 新建仓 |
| 13 | ASND | Ascendis Pharma A/S | +1.1% | +18.64% | 加仓 |
| 14 | ARQT | Arcutis Biotherapeutics Inc | +1.1% | NEW | 新建仓 |
| 15 | HUM | Humana Inc | +1.1% | +73.17% | 加仓 |
| 16 | DHR | Danaher CORP | +1% | +43.51% | 加仓 |
| 17 | SPY | Ss Spdr S&p 500 ETF Trust-us | +0.9% | NEW | 新建仓 |
| 18 | INDV | Indivior Pharmaceuticals, Inc. | +0.9% | +16.91% | 加仓 |
| 19 | UTHR | United Therapeutics CORP | +0.9% | NEW | 新建仓 |
| 20 | BMRN | Biomarin Pharmaceutical Inc | +0.8% | NEW | 新建仓 |
| 21 | ✓ | Merus N V | +0.8% | NEW | 新建仓 |
| 22 | ISRG | Intuitive Surgical Inc | +0.8% | -4.41% | 减仓 |
| 23 | VRNA | Verona Pharma PLC - Adr | +0.7% | NEW | 新建仓 |
| 24 | EW | Edwards Lifesciences CORP | +0.6% | +3.30% | 加仓 |
| 25 | ICLR | ICON Public Limited Company | +0.6% | +114.88% | 加仓 |
| 26 | OSCR | Oscar Health Inc - Class A | +0.5% | -14.61% | 减仓 |
| 27 | MOH | Molina Healthcare Inc | +0.5% | +22.33% | 加仓 |
| 28 | ASND 2.25 04-01-28债券 | Ascendis Pharma A/s | +0.5% | — | 不变 |
| 29 | HCA | Hca Healthcare Inc | +0.4% | -6.68% | 减仓 |
| 30 | PEN | Penumbra Inc | +0.4% | — | 不变 |
| 31 | CMPS | Compass Pathways PLC | +0.3% | +294.28% | 加仓 |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | +0.3% | -17.13% | 减仓 |
| 33 | 2655787D | Blueprint Medicines CORP | +0.2% | +4.29% | 加仓 |
| 34 | AMLX | Amylyx Pharmaceuticals Inc | +0.2% | -12.21% | 减仓 |
| 35 | RZLT | Rezolute Inc | +0.2% | NEW | 新建仓 |
| 36 | IRON | Disc Medicine Inc | +0.1% | NEW | 新建仓 |
| 37 | NBIX | Neurocrine Biosciences Inc | +0.1% | NEW | 新建仓 |
| 38 | VKTX | Viking Therapeutics Inc | +0.1% | NEW | 新建仓 |
| 39 | NEO | Neogenomics Inc | +0.1% | +31.54% | 加仓 |
| 40 | GPCR | Structure Therapeutics Inc | +0.1% | +40.08% | 加仓 |
| 41 | IOBTQ | Io Biotech Inc | 0% | -15.76% | 减仓 |
| 42 | CRBU | Caribou Biosciences Inc | 0% | -45.79% | 减仓 |
| 43 | IOVA | Iovance Biotherapeutics Inc | 0% | EXIT | 清仓 |
| 44 | ✓ | Turnstone Biologics CORP | 0% | EXIT | 清仓 |
| 45 | BOLD | Boundless Bio Inc | 0% | EXIT | 清仓 |
| 46 | CELC | Celcuity Inc | 0% | EXIT | 清仓 |
| 47 | ✓ | Verve Therapeutics Inc | -0.1% | EXIT | 清仓 |
| 48 | ACLXGBX | Arcellx Inc | -0.1% | EXIT | 清仓 |
| 49 | SWTXUSD | Springworks Therapeutics Inc | -0.1% | EXIT | 清仓 |
| 50 | KROS | Keros Therapeutics Inc | -0.1% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，PFM Health Sciences, LP 在 Q2 2025 季度的美股持仓总市值约为 US$11.7亿，共申报了 56 个公开持股仓位。
在 Q2 2025 季度，PFM Health Sciences, LP 按市值排列的前三大核心持股分别为：LLY (17.8%)、THC (7.5%)、MCK (4.5%)。其中最大持股仓位 LLY 占据整体投资组合约 17.8% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
TEVA
市值: US$2076.3万
本季最大获利了结 / 清仓标的
XLV
前期市值: US$6274.0万
在 Q2 2025 季度中，PFM Health Sciences, LP 共进行了 80 项持仓异动，包含新建仓 17 个仓位、加仓 14 个仓位、减仓 23 个仓位以及清仓 26 个仓位。 其中最大新建仓标的为 TEVA。 本季清仓仓位包含 XLV。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。